KOREA PHARMA Co., Ltd. (KOSDAQ: 032300)

KOREA PHARMA Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	32,741	41,424	8,390	56,540	16,865	10,443
Short-Term Investments	-	-	2,000	6,000	2,000	-
Trading Asset Securities	11,228	6,889	52,690	-	-	-
Cash & Short-Term Investments	43,968	48,313	63,080	62,540	18,865	10,443
Cash Growth	-31.32%	-23.41%	0.86%	231.52%	80.64%	38.20%
Accounts Receivable	13,813	14,049	15,331	16,756	15,458	15,026
Other Receivables	453.42	574.37	587.96	441.83	293.24	1,666
Receivables	14,267	14,624	16,419	17,598	15,751	16,693
Inventory	20,781	18,546	17,292	16,910	19,524	12,913
Prepaid Expenses	44.65	82.9	128.49	78.92	78.77	50.94
Other Current Assets	3,938	3,819	1,163	108.56	596.17	281.99
Total Current Assets	82,998	85,385	98,083	97,236	54,815	40,382
Property, Plant & Equipment	23,263	23,534	22,130	20,149	18,824	18,259
Long-Term Investments	3,962	4,003	3,383	4,375	399.27	284.77
Other Intangible Assets	3,167	3,497	2,865	2,973	2,467	2,084
Long-Term Deferred Tax Assets	-	-	563.51	669.94	775.2	1,436
Long-Term Deferred Charges	806.8	907.84	-	-	-	-
Other Long-Term Assets	3,982	3,977	3,923	3,998	4,040	4,301
Total Assets	118,179	121,303	130,947	129,401	81,320	66,747
Accounts Payable	8,374	7,284	7,098	6,721	8,690	8,344
Accrued Expenses	645.49	699	863.27	857.23	787.16	766.93
Short-Term Debt	11,260	18,080	50,774	7,000	10,000	9,771
Current Portion of Long-Term Debt	-	-	2,560	2,960	3,360	5,588
Current Portion of Leases	496.38	661.11	567.64	529.03	540.45	556.53
Current Income Taxes Payable	284.3	171.1	9.13	180.54	-	588.76
Other Current Liabilities	5,711	6,405	7,663	7,250	7,276	8,063
Total Current Liabilities	26,771	33,300	69,535	25,498	30,654	33,678
Long-Term Debt	17,184	15,926	-	43,121	-	1,000
Long-Term Leases	83.27	197.12	727.27	116.67	51.82	143.75
Long-Term Deferred Tax Liabilities	1,066	1,322	-	-	-	-
Other Long-Term Liabilities	0	0	-0	-0	-0	0
Total Liabilities	47,660	52,722	71,132	71,934	34,818	40,149
Common Stock	5,453	5,453	5,453	5,453	5,453	4,393
Additional Paid-In Capital	39,169	39,169	31,175	23,407	17,556	692.31
Retained Earnings	21,631	19,694	21,750	26,019	20,056	16,922
Comprehensive Income & Other	4,265	4,265	1,436	2,588	3,437	4,591
Shareholders' Equity	70,518	68,582	59,815	57,467	46,502	26,598
Total Liabilities & Equity	118,179	121,303	130,947	129,401	81,320	66,747
Total Debt	29,024	34,864	54,629	53,727	13,952	17,059
Net Cash (Debt)	14,945	13,449	8,451	8,813	4,913	-6,616
Net Cash Growth	68.04%	59.13%	-4.11%	79.40%	-	-
Net Cash Per Share	1241.25	1112.95	777.88	801.30	503.84	-752.81
Filing Date Shares Outstanding	10.91	10.91	10.91	10.91	10.91	8.79
Total Common Shares Outstanding	10.91	10.91	10.91	10.91	10.91	8.79
Working Capital	56,227	52,085	28,548	71,738	24,161	6,705
Book Value Per Share	6465.60	6288.02	5484.28	5268.98	4263.64	3026.66
Tangible Book Value	67,351	65,084	56,950	54,494	44,036	24,514
Tangible Book Value Per Share	6175.22	5967.35	5221.60	4996.41	4037.48	2789.51
Land	11,097	11,097	8,067	6,933	6,543	6,543
Buildings	15,652	15,571	15,033	15,094	14,100	14,073
Machinery	12,904	12,560	11,697	11,365	10,395	9,042
Construction In Progress	1,258	952.42	2,039	998.96	945.48	352.36

Source: S&P Capital IQ. Standard template. Financial Sources.